Video
A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement
14:21
C. Michael Gibson and Duk-Woo Park discuss the ADAPT-TAVR Trial presented at ACC 2022.
